Cloudbreak Pharma Inc. (HKG:2592)
Hong Kong · Delayed Price · Currency is HKD 1.195
0.00 (0.00%)
Aug 27, 2026, 3:57 PM HKT
Cloudbreak Pharma Market Cap
Cloudbreak Pharma has a market cap or net worth of 1.01 billion as of August 27, 2026. Its market cap has decreased by -77.26% in one year.
Market Cap
1.01B
Enterprise Value
561.02M
Revenue
1.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.20
ChartMarket Cap Chart
Since July 3, 2025, Cloudbreak Pharma's market cap has decreased from 5.20B to 1.01B, a decrease of -80.60%. That is a compound annual growth rate of -75.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 1.01B | -76.86% |
| Dec 31, 2025 | 4.36B | -16.13% |
| Jul 3, 2025 | 5.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhaoke Ophthalmology | 1.38B |
| Beijing Biostar Pharmaceuticals | 1.24B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.23B |
| CANbridge Pharmaceuticals | 1.18B |
| Sunho Biologics | 970.43M |
| Kintor Pharmaceutical | 871.57M |
| JW (Cayman) Therapeutics Co. | 817.88M |
| 3D Medicines | 773.42M |